FEI Tribunal issues Final Decision in equine anti-doping case

Media updates
25 January 2022 Author: FEI

The FEI Tribunal has issued its Final Decision in an equine anti-doping case involving a Banned Substance and a Controlled Medication Substance.

The horse Calai (FEI ID 105RF80/UAE), ridden by Hassan Bin Ali (FEI ID 10017909/UAE), tested positive for the Banned Substance Arsenic and the Controlled Medication Substance Salicylic Acid, including the metabolite 2-hydroxyethyl salicylate, following samples taken at the CEI2*120 – Bou Thib (UAE) on 12 January 2021.

The athlete did not provide any explanation as to how the Prohibited Substances entered the horse’s system.

In its Final Decision, the FEI Tribunal imposed a two-year suspension on the athlete. The Provisional Suspension of the athlete, which came into effect on 3 March 2021, is credited against the period of ineligibility imposed in the decision, meaning the athlete will be ineligible until 2 March 2023. The athlete was also fined CHF 7,500 and asked to pay costs of CHF 2,000. The results obtained at the event have been disqualified.

The parties can appeal to the Court of Arbitration for Sport (CAS) within 21 days of receipt of the decision

The full Decision is available here

X